** Shares in ALK-Abello ALKb.CO rise 4% after the Danish allergy solutions maker reported Q1 sales and profit above estimates
** The company posted EBIT of 469 million Danish crowns ($71.23 million), exceeding consensus of 392 million crowns, as per Jefferies
** The broker adds that a better gross margin and "notably" lower operating costs resulted in the EBIT beat
** Jefferies also notes ALK-Abello's revenue of 1.52 billion crowns, above the 1.49 billion crown consensus
** The company kept its 2025 guidance of revenue growth target of 9-13% and EBIT margin improvement to around 25%, it said in a press release
** The stock, at its highest since January, is among best performers on the Copenhagen blue chip index .OMXC20
($1 = 6.5839 Danish crowns)
(Reporting by Vera Dvorakova)
((vera.dvorakova@thomsonreuters.com))